1,4-Naphthoquinones: Some Biological Properties and Application

Dmitry Aminin; Sergey Polonik

doi:10.1248/cpb.c19-00911

journal article Jan 01, 2020

1,4-Naphthoquinones: Some Biological Properties and Application

Dmitry Aminin

Sergey Polonik

Chemical and Pharmaceutical Bulletin Vol. 68 No. 1 pp. 46-57 · Pharmaceutical Society of Japan

View at Publisher Save 10.1248/cpb.c19-00911

Topics

No keywords indexed for this article. Browse by subject →

References

91

[1]

1) Thomson R. H., “Naturally occurring quinones,” 4th ed., Blackie Academic and Professional, London-New York, 1997. 10.1007/978-94-009-1551-0

[2]

2) Tomaszkiewicz-Potępa A., Vogt O., Wiadom. Chem., 58, 881–894 (2004).

[3]

3) Hussain H., Krohn K., Ahmad V. U., Miana G. A., Green I. R., ARKIVOC, ii, 145–171 (2007). 10.3998/ark.5550190.0008.204

[4]

4) Lopez L. I., Neryflores S. D., Belmares S. Y., Saenz Galindo A., VITAE, 21, 248–258 (2014). 10.17533/udea.vitae.17322

[5]

5) Wellington K. W., RSC Advances, 5, 20309–20338 (2015). 10.1039/c4ra13547d

[6]

6) Hook I., Mills C., Sheridan H., “Bioactive naphthoquinones from higher plants,” Studies in Natural Product Chemistry, Vol. 41, ed. by Atta-ur-Rahman, Elsevier Science Publisher, Amsterdam, 2014, pp. 119–160. 10.1016/b978-0-444-63294-4.00005-x

[7]

7) Khambay B., Batty D., Cahill M., Denholm I., Mead-Briggs M., Vinall S., Niemeyer H. M., Simmonds M. S. J., Agric. Food Chem., 47, 770–775 (1999). 10.1021/jf980769j

[8]

8) Song G., Kim Y., You Y., Cho H., Ahn B., Arch. Pharm. Res., 24, 190–193 (2001). 10.1007/bf02978254

[9]

9) Riffel A., Medina L. F., Stefani V., Santos R. C., Bizani D., Brandelli A., Braz. Med. Biol. Res., 35, 811–818 (2002). 10.1590/s0100-879x2002000700008

[10]

10) Inbaraj J., Chignell C., Chem. Res. Toxicol., 17, 55–62 (2004). 10.1021/tx034132s

[11]

11) Jeon J. H., Lee C. H., Kim M. K., Lee H. S., J. Korean Soc. Appl. Biol. Chem., 52, 720–725 (2009). 10.3839/jksabc.2009.119

[12]

12) Kanaan Y., Das J., Bakare O., Enwerem N., Berhe S., Beyene D., Williams W., Zhou Y., Copeland R. Jr., Anticancer Res., 29, 191–199 (2009).

[13]

13) Eilenberg H., Pnini-Cohen S., Rahamim Y., Sionov E., Segal E., Carmeli S., Zilberstein A., Exp. Bot., 61, 911–922 (2010). 10.1093/jxb/erp359

[14]

14) Schuck D. C., Ferreira S. B., Cruz L. N., da Rocha D. R., Moraes M. S., Nakabashi M., Rosenthal P. J., Ferreira V. F., Garcia C. R. S., Malar. J., 12, 234–239 (2013). 10.1186/1475-2875-12-234

[15]

15) Sanchez-Calvo J. M., Barbero G. R., Guerrero-Vasquez G., Duran A. G., Macıas M., Rodrıguez-Iglesias M. A., Molinillo J. M. G., Macıas F. A., Med. Chem. Res., 25, 1274–1285 (2016). 10.1007/s00044-016-1550-x

[16]

16) Jordao A. K., Vargas M. D., Pinto A. C., da Silva F. C., Ferreira V. F., RSC Advances, 5, 67909–67963 (2015). 10.1039/c5ra12785h

[17]

17) Li Y., Li C. J., Yu D., Pardee A. B., Mol. Med., 6, 1008–1015 (2000). 10.1007/bf03402052

[18]

18) van der Kooy F., Meyer J. J. M., Lall N., S. Afr. J. Bot., 72, 349–352 (2006). 10.1016/j.sajb.2005.09.009

[19]

19) Mahapatra A., Mativandlela S. P., Binneman B., Fourie P. B., Hamilton C. J., Meyer J. J., van der Kooy F., Houghton P., Lall N., Bioorg. Med. Chem., 15, 7638–7646 (2007). 10.1016/j.bmc.2007.08.064

[20]

20) Sharma M. C., Sharma S., J. Pharmacol. Toxicol., 6, 493–504 (2011). 10.3923/jpt.2011.493.504

[21]

21) Polonik S. G., Tolkach A. M., Stekhova S. I., Shentsova E. B., Uvarova N. I., Pharm. Chem. J., 26, 500–502 (1992). 10.1007/bf00773077

[22]

22) Fedorov S. N., Polonik S. G., Shubina L. K., Kapustina I. N., Stonik V. A., Shastina V. V., Kvak Y. Y., Park D. J., Jean D. O., Kwon J. H., RU Patent 2,372,919 (2009).

[23]

23) Fedorov S. N., Shubina L. K., Kuzmich A. S., Polonik S. G., Open Glycoscience, 4, 1–5 (2011). 10.2174/1875398101104010001

[24]

24) Polonik S. G., Prokof’eva N. G., Agafonova I. G., Uvarova N. I., Pharm. Chem. J., 37, 397–398 (2003). 10.1023/a:1027305110622

[25]

25) Papageorgiou V. P., Assimopoulou A. N., Couladouros E. A., Hepworth D., Nicolaou K. C., Angew. Chem. Int. Ed., 38, 270–300 (1999). 10.1002/(sici)1521-3773(19990201)38:3<270::aid-anie270>3.0.co;2-0

[26]

26) Chen X., Yang L., Zhang N., Turpin J., Buckheit R. W., Osterling C., Oppenheim J. J., Howard Z., Antimicrob. Agents Chemother., 47, 2810–2816 (2003). 10.1128/aac.47.9.2810-2816.2003

[27]

27) Lee H., Magesh V., Nam D., Lee E., Ahn K., Jung M., Kim D., Kim J., Kim S., Yakugaku Zasshi, 128, 161–168 (2008). 10.1248/yakushi.128.1681

[28]

28) Polonik S. G., Chem. Nat. Compd., 45, 247–248 (2009). 10.1007/s10600-009-9286-1

[29]

29) Eremenko E. M., Antimonova O. I., Shekalova O. G., Polonik S. G., Margulis B. A., Guzhova I. V., Cell Tissue Biol., 4, 251–257 (2010). 10.1134/s1990519x10030065

[30]

30) Yehua S., Jiansheng X., Yanguang W., Xun H., Xianfu L., Eur. J. Med. Chem., 45, 2713–2718 (2010).

[31]

31) Tandon V. K., Kumar S., Expert Opin. Ther. Patents, 23, 1087–1108 (2013). 10.1517/13543776.2013.798303

[32]

32) Lebedev A. V., Ivanova M. V., Levitsky D. O., Life Sci., 76, 863–875 (2005). 10.1016/j.lfs.2004.10.007

[33]

33) Lebedev A. V., Ivanova M. V., Levitsky D. O., Hemoglobin, 32, 165–179 (2008). 10.1080/03630260701700017

[34]

34) Elyakov G. B., Maximov O. B., Mishenko N. P., Koltsova E. A., Fedoreev S. A., Glebko L. I., Krasovskaya N. P., Artjukov A. A., US Patent 6,384,084 (1998).

[35]

35) Elyakov G. B., Maximov O. B., Mishenko N. P., Koltsova E. A., Fedoreev S. A., Glebko L. I., Krasovskaya N. P., Artjukov A. A., US Patent 6,410,601 (1998).

[36]

36) Jeong S. H., Kim H. K., Song I.-S., Noh S. J., Marquez J., Ko K. S., Rhee B. D., Kim N., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Han J., Mar. Drugs, 12, 4602–4615 (2014). 10.3390/md12084602

[37]

37) Kim H. K., Youm J. B., Jeong S. N., Lee S. R., Song I.-S., Ko T. H., Pronto J. R., Ko K. S., Rhee B. D., Kim N., Nilius B., Mischchenko N. P., Fedoreyev S. A., Stonik V. A., Han J., Pflugers Arch., 467, 2151–2163 (2015). 10.1007/s00424-014-1648-2

[38]

38) Kim H., Cho S., Heo H., Jeong S., Kim M., Ko K., Rhee B. D., Mischchenko N. P., Vasileva E. A., Fedoreyev S. A., Stonik V. A., Han J., Mar. Drugs, 16, 192 (2018). 10.3390/md16060192

[39]

39) Park J. H., Lee N. K., Lim H. J., et al., Mar. Drugs, 17, 368 (2019).

[40]

40) Yoon C. S., Kim H. K., Mishchenko N. P., Vasileva E. A., Fedoreyev S. A., Stonik V. A., Han J., Mar. Drugs, 17, 2 (2018). 10.3390/md17010002

[41]

41) Agafonova I. G., Kotelnikov V. N., Geltser B. I., Kolosova N. G., Stonik V. A., Appl. Magn. Reson., 49, 217–225 (2018). 10.1007/s00723-017-0960-3

[42]

42) Agafonova I. G., Anufriev V. Ph., Appl. Magn. Reson., 48, 579–587 (2017). 10.1007/s00723-017-0887-8

[43]

43) Bernikova O. G., Sedova K. A., Kharin S. N., Azarov Y. E., Bull. Exp. Biol. Med., 165, 340–343 (2018). 10.1007/s10517-018-4165-z

[44]

44) Mohamed A. S., Sadek S. A., Hassanein S. S., Soliman A. M., J. Surg. Res., 234, 317–324 (2019). 10.1016/j.jss.2018.10.004

[45]

45) Fahmy S. R., Sayed D. A., Soliman A. M., Almortada N. Y., Aal W. E. A., Brazil. J. Biol., 2019, in press.

[46]

46) Soliman A. M., Mohamed A. S., Marie M.-A. S., Austin J Endocrinol Diabetes, 3, 1045–1051 (2016).

[47]

47) Zhang Y. Y., Chen X. H., Qin S. Y., Kim C. S., Tebayashi S., Bia K. S., Biol. Pharm. Bull., 29, 2523–2527 (2006). 10.1248/bpb.29.2523

[48]

48) Singh B., Sharma M. K., Meghwal P. R., Sahu P. M., Singh S., Phytomedicine, 10, 375–380 (2003). 10.1078/0944-7113-00262

[49]

49) Staniforth V., Wang S.-Y., Shyur L.-F., Yang N.-S., J. Biol. Chem., 279, 5877–5885 (2004). 10.1074/jbc.m309185200

[50]

50) Mishra P. D., Verekar S. A., Kulkarni-Almeida A., Roy S. K., Jain S., Balakrishnan R., Deshmukh S. K., Indian J. Chem., 52B, 565–567 (2013).

Showing 50 of 91 references

Cited By

145

Current status of 1,4-Naphthoquinones and their derivatives for wound healing

Pooja Kumari, Vikramjeet Singh · 2024

European Journal of Medicinal Chemi...

Protection Activity of 1,4-Naphthoquinones in Rotenone-Induced Models of Neurotoxicity

Irina Agafonova, Ekaterina Chingizova · 2024

Marine Drugs

p-Toluenesulfonic acid-promoted organic transformations for the generation of molecular complexity

Sanchari Pal, Debjit Das · 2024

Organic & Biomolecular Chemistr...

The Relevance and Insights on 1,4-Naphthoquinones as Antimicrobial and Antitumoral Molecules: A Systematic Review

Gabriela Navarro-Tovar, Sarai Vega-Rodríguez · 2023

Pharmaceuticals

Tetracyclic 1,4-Naphthoquinone Thioglucoside Conjugate U-556 Blocks the Purinergic P2X7 Receptor in Macrophages and Exhibits Anti-Inflammatory Activity In Vivo

Sergey Kozlovskiy, Evgeny Pislyagin · 2023

International Journal of Molecular...

Blue Light Irradiated Metal-, Oxidant-, and Base-Free Cross-Dehydrogenative Coupling of C(sp2)–H and N–H Bonds: Amination of Naphthoquinones with Amines

Raushan Kumar Jha, Monojit Batabyal · 2023

The Journal of Organic Chemistry

Biological Activity of Naphthoquinones Derivatives in the Search of Anticancer Lead Compounds

Alexandra G. Durán, Nuria Chinchilla · 2023

Toxins

Sustainable Synthesis, Antiproliferative and Acetylcholinesterase Inhibition of 1,4- and 1,2-Naphthoquinone Derivatives

Rafaela G. Cabral, Gonçalo Viegas · 2023

Molecules

Metrics

145

Citations

91

References

Details

Published: Jan 01, 2020
Vol/Issue: 68(1)
Pages: 46-57

Authors

D

Dmitry Aminin

G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Science; Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University

S

Sergey Polonik

G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Science

Cite This Article

Dmitry Aminin, Sergey Polonik (2020). 1,4-Naphthoquinones: Some Biological Properties and Application. Chemical and Pharmaceutical Bulletin, 68(1), 46-57. https://doi.org/10.1248/cpb.c19-00911

1,4-Naphthoquinones: Some Biological Properties and Application

You May Also Like